World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
26176
World Ranking
13245
National Ranking
6746

Sofia D. Merajver publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sofia D. Merajver sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 420 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sofia D. Merajver D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sofia D. Merajver sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sofia D. Merajver is affiliated with the University of Michigan-Ann Arbor in the United States. Their research spans multiple fields within medicine and biochemistry, genetics, and molecular biology, with a strong focus on oncology and cancer-related studies.

Their primary fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, they have contributed extensively to subfields such as:

  • Molecular Biology
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Genetics

The main topics covered in their work are:

  • BRCA gene mutations in cancer
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Cancer, Hypoxia, and Metabolism
  • Brain Metastases and Treatment
  • Lung Cancer Research Studies
  • Cancer Cells and Metastasis

They have published frequently in the following venues:

  • Cancer Research
  • Journal of Clinical Oncology
  • Journal of the National Comprehensive Cancer Network
  • The Journal of Urology
  • Clinical Cancer Research

Among notable recent papers coauthored or authored by Sofia D. Merajver are:

  • Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology (2021), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020 (2020), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024 (2023), Journal of the National Comprehensive Cancer Network
  • TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination (2020), Journal of Clinical Investigation
  • G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy (2021), Science Advances

Their frequent co-authors include:

  • Nathan Merrill
  • Matthew B. Soellner
  • Liwei Bao
  • Peter Ulintz
  • Habib Serhan

Best Publications

  • The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

    S.V. Tavtigian;J. Simard;J. Rommens;F. Couch

  • Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2021

    Mary B. Daly;Tuya Pal;Michael P. Berry;Saundra S. Buys

  • BRCA1 regulates human mammary stem/progenitor cell fate

    Suling Liu;Christophe Ginestier;Emmanuelle Charafe-Jauffret;Hailey Foco

  • NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

    Mary B. Daly;Robert Pilarski;Michael Berry;Saundra S. Buys

  • International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

    S. Dawood;S. D. Merajver;P. Viens;P. B. Vermeulen

  • Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

    Sofia D. Merajver;Trinh M. Pham;Rosemarie F. Caduff;Martha Chen

  • Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

    Quintin Pan;Celina G. Kleer;Kenneth L. Van Golen;Jennifer Irani

  • Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians

    Kent F. Hoskins;Jill E. Stopfer;Kathleen A. Calzone;Sofia D. Merajver

  • Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

    Steven A. Narod;Marie Pierre Dubé;Jan Klijn;Jan Lubinski

  • NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

    Mary B. Daly;Robert Pilarski;Matthew B. Yurgelun;Michael P. Berry

  • RhoC GTPase, a Novel Transforming Oncogene for Human Mammary Epithelial Cells That Partially Recapitulates the Inflammatory Breast Cancer Phenotype

    Kenneth L. van Golen;Zhi-Fen Wu;Xiao Tan Qiao;Li Wei Bao

  • BRCA2 germline mutations in male breast cancer cases and breast cancer families.

    Fergus J. Couch;Linda M. Farid;Michelle L. DeShano;Sean V. Tavtigian

  • Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study

    George J. Brewer;Robert D. Dick;Damanjit K. Grover;Virginia LeClaire

  • International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

    Kelly A. Metcalfe;Daphna Birenbaum-Carmeli;Jan Lubinski;Jacek Gronwald

  • Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer

    Lori J. Pierce;Albert M. Levin;Timothy R. Rebbeck;Merav A. Ben-David

  • A Novel Putative Low-Affinity Insulin-like Growth Factor-binding Protein, LIBC (Lost in Inflammatory Breast Cancer), and RhoC GTPase Correlate with the Inflammatory Breast Cancer Phenotype

    Kenneth L. Van Golen;Seena Davies;Zhi Fen Wu;Yun Fang Wang

  • Genetic/familial high-risk assessment: Breast and ovarian, version 2.2015 Featured updates to the NCCN guidelines

    Mary B. Daly;Robert Pilarski;Jennifer E. Axilbund;Michael Berry

  • Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23

    B. Fisher;S. Anderson;E. Tan-Chiu;N. Wolmark

  • BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants

    Fons Elstrodt;Antoinette Hollestelle;Jord H.A. Nagel;Michael Gorin

  • Characterization of RhoC expression in benign and malignant breast disease: A potential new marker for small breast carcinomas with metastatic ability

    Celina G. Kleer;Kenneth L. Van Golen;Yanhong Zhang;Zhi Fen Wu

Frequent Co-Authors

Celina G. Kleer
Celina G. Kleer University of Michigan–Ann Arbor
George J. Brewer
George J. Brewer University of Michigan–Ann Arbor
Max S. Wicha
Max S. Wicha University of Michigan–Ann Arbor
Judy Garber
Judy Garber Harvard University
Lisa A. Newman
Lisa A. Newman Cornell University
Mary B. Daly
Mary B. Daly Fox Chase Cancer Center
Theodoros N. Teknos
Theodoros N. Teknos The Ohio State University
Kenneth Offit
Kenneth Offit Memorial Sloan Kettering Cancer Center
Jeffrey N. Weitzel
Jeffrey N. Weitzel Natera (United States)
Jun Li
Jun Li University of Oklahoma Health Sciences Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medical careers beyond the traditional path of an MD in the USA, several flexible online options are available. Healthcare administration is a growing field for those who want leadership roles in medical settings. Choosing from which online healthcare administration programs have cahme accreditation? ensures your degree is recognized for its quality and rigor, providing a competitive edge in the job market.

Nursing is another high-demand sector. RNs looking to advance without extensive in-person requirements should explore rn to bsn programs no clinicals. These programs are ideal for working nurses seeking to upgrade their qualifications at their own pace.

For nurses ready to take on top clinical and leadership roles, Doctor of Nursing Practice degrees are becoming more accessible online. Options like the quickest dnp program or searching for dnp programs tailored for working professionals can accelerate your path to advanced practice. Each of these pathways allows you to expand your impact in healthcare while balancing your work and personal commitments.

Best Scientists Citing Sofia D. Merajver

Trending Scientists

Recently Published Articles